dactinomycin and bromocriptine

dactinomycin has been researched along with bromocriptine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's2 (33.33)18.2507
2000's1 (16.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Levy, A; Lightman, SL1
Abel, U; Edler, L; Fritze, D; Kaufmann, M; Massner, B; Queisser, W; Schmid, H; Schmidt, R; Westerhausen, M1
Costello, LC; Franklin, RB; Liu, Y1

Reviews

1 review(s) available for dactinomycin and bromocriptine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for dactinomycin and bromocriptine

ArticleYear
Prospective randomized trial concerning hyper- and normoprolactinemia and the use of bromoergocryptine in patients with metastatic breast cancer.
    Onkologie, 1986, Volume: 9, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bromocriptine; Cyclophosphamide; Dactinomycin; Female; Fluorouracil; Humans; Hyperprolactinemia; Medroxyprogesterone; Medroxyprogesterone Acetate; Methotrexate; Middle Aged; Neoplasm Metastasis; Prognosis; Prolactin; Vincristine

1986

Other Studies

4 other study(ies) available for dactinomycin and bromocriptine

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Bromocriptine reduces rat thyrotropin beta-subunit mRNA stability.
    Journal of endocrinological investigation, 1990, Volume: 13, Issue:1

    Topics: Administration, Oral; Animals; Base Sequence; Blotting, Northern; Bromocriptine; Cells, Cultured; Dactinomycin; Dopamine; Gene Expression Regulation; Male; Molecular Sequence Data; Nucleic Acid Hybridization; Oligonucleotide Probes; Pituitary Gland, Anterior; Rats; Rats, Inbred Strains; RNA, Messenger; Thyrotropin; Transcription, Genetic

1990
Prolactin specifically regulates citrate oxidation and m-aconitase of rat prostate epithelial cells.
    Metabolism: clinical and experimental, 1996, Volume: 45, Issue:4

    Topics: Aconitate Hydratase; Animals; Blotting, Western; Bromocriptine; Citrates; Cycloheximide; Dactinomycin; Epithelial Cells; Epithelium; Hormone Antagonists; Kidney; Male; Mitochondria; Oxidation-Reduction; Prolactin; Prostate; Rats; Rats, Wistar

1996